Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "organic"

153 News Found

MFine and LifeCell form JV ‘LifeWell’
Digitisation | July 11, 2022

MFine and LifeCell form JV ‘LifeWell’

LifeWell Raises USD 80M from OrbiMed to Build Large Scale Healthcare Delivery Platform with Full stack Diagnostics~


Vaccizone selects Exothera for GMP manufacturing of its SARS?CoV?2 vaccine
News | July 06, 2022

Vaccizone selects Exothera for GMP manufacturing of its SARS?CoV?2 vaccine

Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells


HIL to commercialise VCRC Bti bio-larvicide technology for mosquito vector control programs
News | June 28, 2022

HIL to commercialise VCRC Bti bio-larvicide technology for mosquito vector control programs

HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project


Aurobindo Pharma board approves acquisition of GLS Pharma
News | June 20, 2022

Aurobindo Pharma board approves acquisition of GLS Pharma

The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.


GSK to form consumer healthcare business ‘Haleon’
News | June 03, 2022

GSK to form consumer healthcare business ‘Haleon’

The proposed demerger is the most significant corporate change for GSK in the last 20 years


BDR Pharma receives Rs. 685 crore of PE investment
News | May 17, 2022

BDR Pharma receives Rs. 685 crore of PE investment

Multiples is the first private equity (PE) investor in the company


Merck KGaA first quarter earnings grows on higher volumes, margins
News | May 15, 2022

Merck KGaA first quarter earnings grows on higher volumes, margins

Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter


Indian Pharma Market slips for third month in a row: Anand Rathi
News | May 10, 2022

Indian Pharma Market slips for third month in a row: Anand Rathi

According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)


Sumitomo Chemical to build new API and intermediates plant in Japan
News | April 01, 2022

Sumitomo Chemical to build new API and intermediates plant in Japan

The plant is scheduled to come on stream in September 2024


Lonza appoints Christian Seufert as President of CHI Division
People | March 23, 2022

Lonza appoints Christian Seufert as President of CHI Division

Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses